[3H] citalopram binding to serotonin transporter sited in Minnow brains

被引:36
|
作者
Gould, Georgianna G.
Brooks, Bryan W.
Frazer, Alan
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Baylor Univ, Inst Biomed Sci, Dept Environm Studies, Waco, TX 76798 USA
关键词
D O I
10.1111/j.1742-7843.2007.00100.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mammalian serotonin (SERT) and norepinephrine transporters (NET) are target sites for antidepressants and are affected by pesticide exposures. Herein, we examined whether golden shiner (Notemigonus crysoleucas) or fathead minnow (Pimphales promelas) SERTs and catecholamine transporters respond comparably to mammalian SERTs and NETs. We compared the pharmacological profiles of central SERT and NET binding sites of the golden shiner minnow to those of rats. Homogenate binding with the radioligand [H-3] citalopram indicated that golden shiner SERT has a K-D of 7 +/- 3 nM and a B-max of 226 +/- 46 fmol/mg protein. These values are similar to those of rat cortical SERT (K-D 1.4 +/- 0.1 nM and B-max 240 48 fmol/mg protein). We also examined SERT binding in fathead minnow brain, and found it similar to that of the golden shiner. A putative golden shiner NET, measured using [H-3] nisoxetine, had K-D = 12 +/- 5 nM and B-max = 187 +/- 49 fmol/mg protein, whereas rat hippocampal NET had K-D = 5 2 nM and B-max 93 8 fmol/mg protein. Minnow SERT and NET binding is displaceable by selective reuptake inhibitors. Finally, we exposed zebrafish (Dania rerio) to the serotonin reuptake inhibiting antidepressant sertraline or the organophosphate chlorpyrifos for 21 days. After either treatment, SERT binding was reduced by 50% (n = 3-6, P < 0.05). In summary, minnow central SERT and NET express slightly lower affinity for antidepressants than rats. However, magnitudes of affinity are similar, and minnow SERT binding is decreased by chronic sertraline or chlorpyrifos administration.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [1] Inhibition of [3H]Citalopram binding to the rat brain serotonin transporter by amaryllidaceae alkaloids
    Elgorashi, EE
    Stafford, GI
    Jäger, AK
    Van Staden, J
    [J]. PLANTA MEDICA, 2006, 72 (05) : 470 - 473
  • [2] R-citalopram decreases the association of [3H]-S-citalopram with the human serotonin transporter by an allosteric mechanism
    Wiborg, O
    Sánchez, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S217 - S217
  • [3] Serotonin transporter gene polymorphisms and platelet [3H]paroxetine binding in premenstrual dysphoria
    Melke, J
    Westberg, L
    Landén, M
    Sundblad, C
    Eriksson, O
    Baghei, F
    Rosmond, R
    Eriksson, E
    Ekman, A
    [J]. PSYCHONEUROENDOCRINOLOGY, 2003, 28 (03) : 446 - 458
  • [4] Pharmacological differences of [3H]citalopram binding to the 5-HT transporter among animal species
    Faedo, S.
    Negri, M.
    Wren, P. B.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 142 - 142
  • [5] High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains
    Rosel, P
    Arranz, B
    Vallejo, J
    Oros, M
    Menchon, JM
    Alvarez, P
    Navarro, MA
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (8-9) : 921 - 929
  • [6] High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains
    P. Rosel
    B. Arranz
    J. Vallejo
    M. Oros
    J. M. Menchón
    P. Alvarez
    M. A. Navarro
    [J]. Journal of Neural Transmission, 1997, 104 : 921 - 929
  • [7] Characterization of an allosteric citalopram-binding site at the serotonin transporter
    Chen, FH
    Larsen, MB
    Neubauer, HA
    Sánchez, C
    Plenge, P
    Wiborg, O
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 92 (01) : 21 - 28
  • [8] Identification of the binding site of the SSRI citalopram on the human serotonin transporter
    Palmer, Hannah M.
    O'Donnell, Kelsey L.
    Veeramachaneni, Rathna J.
    Cascio, Michael
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [9] Distribution of [3H]Citalopram binding sites in the nonhuman primate brain
    Smith, HR
    Daunais, JB
    Nader, MA
    Porrino, LJ
    [J]. ADVANCING FROM THE VENTRAL STRIATUM TO THE EXTENDED AMYGDALA: IMPLICATIONS FOR NEUROPSYCHIATRY AND DRUG ABUSE: IN HONOR OF LENNART HEIMER, 1999, 877 : 700 - 702
  • [10] Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains
    Rosel, P
    Arranz, B
    Vallejo, J
    Oros, M
    Crespo, JM
    Menchon, JM
    Navarro, MA
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 1998, 82 (03) : 161 - 170